Harbor Investment Advisory, LLC Bluebird Bio, Inc. Transaction History

Harbor Investment Advisory, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 12, 2021	SELL	$11.24 - $21.0 $3,372 - $6,300	-300 Closed	0 $0
Q2 2021 Jul 27, 2021	SELL	$18.04 - $22.09 $54,282 - $66,468	-3,009 Reduced 90.93%	300 $10,000
Q1 2021 Apr 16, 2021	SELL	$16.59 - $33.89 $29,032 - $59,307	-1,750 Reduced 34.59%	3,309 $100,000
Q4 2020 Feb 04, 2021	SELL	$27.5 - $37.92 $60,500 - $83,424	-2,200 Reduced 30.31%	5,059 $219,000
Q3 2020 Oct 23, 2020	BUY	$34.44 - $43.75 $205,227 - $260,706	5,959 Added 458.38%	7,259 $392,000
Q2 2020 Jul 16, 2020	BUY	$27.12 - $45.97 $3,037 - $5,148	112 Added 9.43%	1,300 $79,000
Q1 2020 May 11, 2020	BUY	$26.16 - $63.5 $12,766 - $30,988	488 Added 69.71%	1,188 $55,000
Q4 2019 Jan 16, 2020	BUY	$46.96 - $61.67 $32,872 - $43,169	700 New	700 $61,000

151

63.4M

264K

428K

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $23.1M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

Get notified when there are updates to the investment portfolio of Harbor Investment Advisory, LLC, based on Form 13F filings with the SEC.

Stay updated on Harbor Investment Advisory, LLC with notifications on news.